Thursday, October 25, 2018 9:56:09 AM
On October 24, 2018, Repro Med Systems, Inc. dba RMS Medical Products (the “Company”) held an earnings conference call for the quarter ended September 30, 2018. A copy of the conference call transcript is attached hereto as Exhibit 99.1. The transcript contains certain supplemental information identified by “[ ]” related to management’s responses to investor questions.
Horton wants to grow the company. That is why they worked to help put in the current board members and management team. It is not Horton's intent to flip the stock. Exercising the warrants strengthens their position in the event of a proxy fight by the former ceo and sealfon. Just my opinion.
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM